These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38673780)

  • 1. Cognitive Impairment Related to Chronic Kidney Disease Is Associated with a Decreased Abundance of Membrane-Bound Klotho in the Cerebral Cortex.
    Rodríguez-Ortiz ME; Jurado-Montoya D; Valdés-Díaz K; García-Sáez RM; Torralbo AI; Obrero T; Vidal-Jiménez V; Jiménez MJ; Carmona A; Guerrero F; Pendón-Ruiz de Mier MV; Rodelo-Haad C; Canalejo A; Rodríguez M; Soriano-Cabrera S; Muñoz-Castañeda JR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Interaction of Soluble Klotho with FGF23 in the Pathobiology of Aortic Valve Lesions Induced by Chronic Kidney Disease.
    The E; Zhai Y; Yao Q; Ao L; Fullerton DA; Meng X
    Int J Biol Sci; 2024; 20(9):3412-3425. PubMed ID: 38993571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
    Epstein M; Freundlich M
    Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML; Olgaard K; Lewin E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Soluble
    Wang Q; Su W; Shen Z; Wang R
    Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of klotho deletion from bone during chronic kidney disease.
    Kaludjerovic J; Komaba H; Lanske B
    Bone; 2017 Jul; 100():50-55. PubMed ID: 28232146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study.
    Kužmová Z; Kužma M; Gažová A; Kovářová M; Jackuliak P; Killinger Z; Kyselovič J; Payer J
    Physiol Res; 2021 Nov; 70(Suppl 1):S43-S51. PubMed ID: 35503049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
    Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis.
    Liu BH; Chong FL; Yuan CC; Liu YL; Yang HM; Wang WW; Fang QJ; Wu W; Wang MZ; Tu Y; Wan ZY; Wan YG; Wu GW
    Front Pharmacol; 2020; 11():586725. PubMed ID: 33708111
    [No Abstract]   [Full Text] [Related]  

  • 14. Klotho, Aging, and the Failing Kidney.
    Buchanan S; Combet E; Stenvinkel P; Shiels PG
    Front Endocrinol (Lausanne); 2020; 11():560. PubMed ID: 32982966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation both increases and causes resistance to FGF23 in normal and uremic rats.
    Rodríguez-Ortiz ME; Díaz-Tocados JM; Muñoz-Castañeda JR; Herencia C; Pineda C; Martínez-Moreno JM; Montes de Oca A; López-Baltanás R; Alcalá-Díaz J; Ortiz A; Aguilera-Tejero E; Felsenfeld A; Rodríguez M; Almadén Y
    Clin Sci (Lond); 2020 Jan; 134(1):15-32. PubMed ID: 31860056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
    Xie J; Yoon J; An SW; Kuro-o M; Huang CL
    J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
    Gutiérrez OM
    J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth-factor 23-Klotho axis is associated with systemic inflammation and myokine profile in children with chronic kidney disease.
    Karava V; Kondou A; Dotis J; Christoforidis A; Taparkou A; Farmaki E; Printza N
    Hormones (Athens); 2024 Sep; 23(3):517-526. PubMed ID: 39112785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.